Bulls Blast Drug Stock on COVID-19 Buzz

COVID-19 cases in the U.S. continue to rise, however

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Market Recap
 
 

3/02/2020

A stock that yields 67% a year? Really?


If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - then go here ASAP.

unit
Dow Bounces Back, Logs Best Day Since 2009

By Patrick Martin

Share On

Stock bounced back in a big way today, as Wall Street attempted to rectify losses incurred during the worst week since the 2008 financial crisis. The Dow turned in an over 1,2000 point win -- its biggest percentage gain since March 2009 -- and snapped a seven-day losing streak in the process. All three benchmarks notched wins of 4% higher or more. Nevertheless, investors are still unpacking the coronavirus outbreak that has resulted in over 3,000 deaths with more coming from outside of China, while the U.S. now has a total of 91 verified COVID-19 cases.

 

Continue reading for more on today's market, including:

  • This drug stock is breaking out after a COVID-19 vaccine update.
  • Twitter stock was on the rise today amid reports of a CEO switch.
  • Plus, Apple gets analyst upgrade; options volume takes off for 2 airline stocks; and JD.Com bounces back. 
>> Continue reading...
LATEST HEADLINES

>> Options Players, Analysts Flock to JD Stock After Earnings
Jefferies lifted its price target to $53.40 from $50
>> Options Bulls Blast Volatile Moderna Stock
Moderna is eyeing its highest close on record
>> Airliner Puts Pop as COVID-19 Cases Rise
Both AAL and DAL are tremendously oversold
>> Dow Surges on Apple, Walmart Outperformance
The blue-chip index is in recovery mode this afternoon
>> Analyst Sings Western Digital's Praises
Stifel upgraded WDC to "buy" from "hold"
Sponsored

There May Only Be Hours Left To Snag This "5G Savior" For $5 A Share


Up to $31 billion in new business... as much as $6.6 billion in patent royalties... and its biggest competitor banned in America... this 5G tech stock could be the opportunity of a lifetime. But you'll need to make your move quickly... as soon as word gets out, banks and hedge funds could run the price up 10, 20, or 50X. Grab this powerhouse for $5 a share while you still can. Click here for details.

 

To ensure delivery of Schaeffer's Market Recap, add us to your contacts! For more information, please visit this link for further instructions.

This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Market Recap or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Market Recap? You can unsubscribe here.

For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions.

Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:

Schaeffer's Market Recap

No comments:

Post a Comment